Ryuhei Ishihara

Osaka, Japan

Last Updated: 09/26/2026

Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 20 publications

Factors Associated with Glucocorticoid Withdrawal in Systemic Lupus Erythematosus: A Multicentre ANSWER-SLE Cohort.

Factors Associated with Glucocorticoid Withdrawal in Systemic Lupus Erythematosus: A Multicentre ANSWER-SLE Cohort.

Journal: Modern rheumatology
Published: May 07, 2026

Preclinical Rheumatoid Arthritis: Pathogenesis, Risk Stratification, and Therapeutic Interception.

Preclinical Rheumatoid Arthritis: Pathogenesis, Risk Stratification, and Therapeutic Interception.

Journal: Journal of clinical medicine
Published: April 06, 2026

JCS 2026 Guideline on Management of Large Vessel Vasculitis.

JCS 2026 Guideline on Management of Large Vessel Vasculitis.

Journal: Circulation journal : official journal of the Japanese Circulation Society
Published: March 22, 2026

Systematic Review and Meta-Analysis for JCS 2026 Guideline on Management of Large-Vessel Vasculitis.

Systematic Review and Meta-Analysis for JCS 2026 Guideline on Management of Large-Vessel Vasculitis.

Journal: Circulation journal : official journal of the Japanese Circulation Society
Published: February 15, 2026

Macrophage Activation Syndrome Associated with Adult-onset Still's Disease Successfully Treated with Plasma Exchange and Canakinumab.

Macrophage Activation Syndrome Associated with Adult-onset Still's Disease Successfully Treated with Plasma Exchange and Canakinumab.

Journal: Internal medicine (Tokyo, Japan)
Published: February 01, 2026

Connective Tissue Disease-Associated Pulmonary Arterial Hypertension: Current Therapeutic Strategies and Future Prospects.

Connective Tissue Disease-Associated Pulmonary Arterial Hypertension: Current Therapeutic Strategies and Future Prospects.

Journal: Biomolecules
Published: December 12, 2025

Hepatocyte growth factor as a driver of synovial inflammation and therapeutic resistance in rheumatoid arthritis.

Hepatocyte growth factor as a driver of synovial inflammation and therapeutic resistance in rheumatoid arthritis.

Journal: Frontiers in immunology
Published: October 04, 2025

The Type I Interferon Axis in Systemic Autoimmune Diseases: From Molecular Pathways to Targeted Therapy.

The Type I Interferon Axis in Systemic Autoimmune Diseases: From Molecular Pathways to Targeted Therapy.

Journal: Biomolecules
Published: September 30, 2025

Uncovering the New Biology of Giant Cell Arteritis to Guide Therapeutic Strategies.

Uncovering the New Biology of Giant Cell Arteritis to Guide Therapeutic Strategies.

Journal: Journal of clinical medicine
Published: July 29, 2025

Lupus podocytopathy as a first renal manifestation in long-standing systemic lupus erythematosus: a case report.

Lupus podocytopathy as a first renal manifestation in long-standing systemic lupus erythematosus: a case report.

Journal: Modern rheumatology case reports
Published: July 08, 2025

A case of IgG4-related disease potentially triggered by COVID-19 vaccination: longitudinal serum IgG4 monitoring from prevaccination.

A case of IgG4-related disease potentially triggered by COVID-19 vaccination: longitudinal serum IgG4 monitoring from prevaccination.

Journal: Modern rheumatology case reports
Published: April 15, 2025

Comparative Insights on IL-5 Targeting with Mepolizumab and Benralizumab: Enhancing EGPA Treatment Strategies.

Comparative Insights on IL-5 Targeting with Mepolizumab and Benralizumab: Enhancing EGPA Treatment Strategies.

Journal: Biomolecules
Published: February 08, 2025
Showing 1-12 of 20

Last Updated: 09/26/2026